Evidence map›Paper›PMID 25024069›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Developmental and adaptive functioning in children with retinoblastoma: a longitudinal investigation.

Victoria W Willard, Ibrahim Qaddoumi, Si Chen, Hui Zhang, Rachel Brennan, Carlos Rodriguez-Galindo, Matthew W Wilson, Sean Phipps

Abstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Retinoblastoma and vision.Eye (London, England) · 2023
    Review
  3. Article
  4. Prenatal ambient pesticide exposure and childhood retinoblastoma.International journal of hygiene and environmental health · 2022
    Article
  5. Cognitive and Adaptive Functioning in Youth With Retinoblastoma: A Longitudinal Investigation Through 10 Years of Age.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Retinoblastoma.Nature reviews. Disease primers · 2015
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Victoria W WillardVictoria W. Willard, Ibrahim Qaddoumi, Si Chen, Hui Zhang, Rachel Brennan, and Sean Phipps, St Jude Children's Research Hospital; Matthew W. Wilson, University of Tennessee, Memphis, TN; and Carlos Rodriguez-Galindo, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
Ibrahim QaddoumiVictoria W. Willard, Ibrahim Qaddoumi, Si Chen, Hui Zhang, Rachel Brennan, and Sean Phipps, St Jude Children's Research Hospital; Matthew W. Wilson, University of Tennessee, Memphis, TN; and Carlos Rodriguez-Galindo, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
Si ChenVictoria W. Willard, Ibrahim Qaddoumi, Si Chen, Hui Zhang, Rachel Brennan, and Sean Phipps, St Jude Children's Research Hospital; Matthew W. Wilson, University of Tennessee, Memphis, TN; and Carlos Rodriguez-Galindo, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
Hui ZhangVictoria W. Willard, Ibrahim Qaddoumi, Si Chen, Hui Zhang, Rachel Brennan, and Sean Phipps, St Jude Children's Research Hospital; Matthew W. Wilson, University of Tennessee, Memphis, TN; and Carlos Rodriguez-Galindo, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
Rachel BrennanVictoria W. Willard, Ibrahim Qaddoumi, Si Chen, Hui Zhang, Rachel Brennan, and Sean Phipps, St Jude Children's Research Hospital; Matthew W. Wilson, University of Tennessee, Memphis, TN; and Carlos Rodriguez-Galindo, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
Carlos Rodriguez-GalindoVictoria W. Willard, Ibrahim Qaddoumi, Si Chen, Hui Zhang, Rachel Brennan, and Sean Phipps, St Jude Children's Research Hospital; Matthew W. Wilson, University of Tennessee, Memphis, TN; and Carlos Rodriguez-Galindo, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
Matthew W WilsonVictoria W. Willard, Ibrahim Qaddoumi, Si Chen, Hui Zhang, Rachel Brennan, and Sean Phipps, St Jude Children's Research Hospital; Matthew W. Wilson, University of Tennessee, Memphis, TN; and Carlos Rodriguez-Galindo, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
Sean PhippsVictoria W. Willard, Ibrahim Qaddoumi, Si Chen, Hui Zhang, Rachel Brennan, and Sean Phipps, St Jude Children's Research Hospital; Matthew W. Wilson, University of Tennessee, Memphis, TN; and Carlos Rodriguez-Galindo, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA. sean.phipps@stjude.org.
General Department of Preventive Medicine · VN

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
NCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

purposeTo determine the developmental trajectory of early cognitive and adaptive skills in young children with retinoblastoma from diagnosis to 5 years of age. PATIENTS AND

methodsNinety-four patients with retinoblastoma treated according to an institutional protocol underwent serial assessments of cognitive and adaptive functioning at age 6 months and 1, 2, 3, and 5 years. Data were analyzed by treatment strata, with patients with 13q deletion analyzed separately.

resultsAt baseline, across all patients (except those with 13q deletion), developmental functioning was comparable with the normative mean, with mean scores for all strata within the average range. However, at age 5 years, developmental functioning was in the low average range and significantly below normative means. The trajectories of developmental functioning demonstrated significant decline over time, although this varied by treatment group/strata. Patients treated with enucleation only evidenced the greatest decline in cognitive functioning; significant change was not observed in patients treated with other modalities. Notable declines in parent-reported communication skills were observed in the majority of patients. Patients with 13q deletion evidenced delayed cognitive functioning at baseline, but minimal declines were observed through age 3 years. However, significant decreases in adaptive functioning were demonstrated over time for the 13q deletion subset.

conclusionThe declines in functioning observed in this study were unexpected, as was the poorer performance of the enucleation-only group. This highlights the necessity of continuing to assess cognitive functioning in patients with retinoblastoma as they age. Additional research is necessary to determine the long-term trajectory of cognitive development in this population.

Indexed as

Adaptation, PhysiologicalChildChild, PreschoolCognitionFemaleHumansInfantInfant, NewbornLongitudinal StudiesMaleRetinal NeoplasmsRetinoblastoma

Identifiers

PMID25024069
PMCPMC4979168
OpenAlexW2094531585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.